Recently, a series of hot spot mutations in the YEATS domain of ENL, also known as MLLT1, have been identified in 5%–9% of nephroblastoma patients, making it the most frequently mutated epigenetic regulator in the disease (12). Here, MLLT1 is linked to Nephroblastoma.